136 related articles for article (PubMed ID: 28380403)
1. 5'-Triphosphate siRNA targeting MDR1 reverses multi-drug resistance and activates RIG-I-induced immune-stimulatory and apoptotic effects against human myeloid leukaemia cells.
Li D; Gale RP; Liu Y; Lei B; Wang Y; Diao D; Zhang M
Leuk Res; 2017 Jul; 58():23-30. PubMed ID: 28380403
[TBL] [Abstract][Full Text] [Related]
2. Modulating multidrug resistance gene in leukaemia cells by short interfering RNA.
Lim MN; Lau NS; Chang KM; Leong CF; Zakaria Z
Singapore Med J; 2007 Oct; 48(10):932-8. PubMed ID: 17909680
[TBL] [Abstract][Full Text] [Related]
3. [siRNA silences mdr1 gene expression and reverses apoptosis resistance of K562/ADM cells line].
Wei HL; Gao LP; Jing T; Zhao HS; Yi J; Sun J; Han J
Zhonghua Xue Ye Xue Za Zhi; 2007 Jun; 28(6):388-90. PubMed ID: 17939404
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of MDR1 increases the sensitivity to adriamycin in drug resistant gastric cancer cells.
Zhu CY; Lv YP; Yan DF; Gao FL
Asian Pac J Cancer Prev; 2013; 14(11):6757-60. PubMed ID: 24377601
[TBL] [Abstract][Full Text] [Related]
5. Reversal of adriamycin resistance in human mammary cancer cells by small interfering RNA of MDR1 and MDR3 genes.
Xiao L; Gao R; Lu S; Ren L; Wang Z
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(6):735-7. PubMed ID: 17357504
[TBL] [Abstract][Full Text] [Related]
6. [Screening effective sequences of small interfering RNAs targeting MDR1 gene in human gastric cancer SGC7901/VCR cells].
Gao FL; Wang F; Wu JL; LE XP; Zhang QX
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):178-82. PubMed ID: 16875600
[TBL] [Abstract][Full Text] [Related]
7. With no interaction, knockdown of Apollon and MDR1 reverse the multidrug resistance of human chronic myelogenous leukemia K562/ADM cells.
Chen JR; Jia XH; Wang H; Yi YJ; Li YJ
Oncol Rep; 2017 May; 37(5):2735-2742. PubMed ID: 28358418
[TBL] [Abstract][Full Text] [Related]
8. [Cytological Study in vitro on Co-delivery of siRNA and Paclitaxel within Solid Lipid Nanoparticles to Overcome Multidrug Resistance in Tumors].
Huang R; Yao X; Chen Y; Sun X; Lin Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2016 Feb; 33(1):108-14. PubMed ID: 27382749
[TBL] [Abstract][Full Text] [Related]
9. Antimultidrug-resistant effect and mechanism of a novel CA-4 analogue MZ3 on leukemia cells.
Xu D; Fang L; Zhu Q; Hu Y; He Q; Yang B
Pharmazie; 2008 Jul; 63(7):528-33. PubMed ID: 18717489
[TBL] [Abstract][Full Text] [Related]
10. [Regulatory effect of small interfering RNA targeting multidrug resistant protein 1 on chemosensitivity of human multiforme glioblastoma cell line BT325].
Zhao P; Zhang YZ; Sun MZ
Ai Zheng; 2005 Dec; 24(12):1436-41. PubMed ID: 16351788
[TBL] [Abstract][Full Text] [Related]
11. siRNA silencing EZH2 reverses cisplatin-resistance of human non-small cell lung and gastric cancer cells.
Zhou W; Wang J; Man WY; Zhang QW; Xu WG
Asian Pac J Cancer Prev; 2015; 16(6):2425-30. PubMed ID: 25824776
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous targeting of MCL1 and ABCB1 as a novel strategy to overcome drug resistance in human leukaemia.
Ji M; Li J; Yu H; Ma D; Ye J; Sun X; Ji C
Br J Haematol; 2009 Jun; 145(5):648-56. PubMed ID: 19344413
[TBL] [Abstract][Full Text] [Related]
13. Restoration of chemosensitivity by multifunctional micelles mediated by P-gp siRNA to reverse MDR.
Shen J; Wang Q; Hu Q; Li Y; Tang G; Chu PK
Biomaterials; 2014 Oct; 35(30):8621-34. PubMed ID: 25002258
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma.
Susa M; Iyer AK; Ryu K; Choy E; Hornicek FJ; Mankin H; Milane L; Amiji MM; Duan Z
PLoS One; 2010 May; 5(5):e10764. PubMed ID: 20520719
[TBL] [Abstract][Full Text] [Related]
15. Modulation of drug resistance in ovarian cancer cells by inhibition of protein kinase C-alpha (PKC-α) with small interference RNA (siRNA) agents.
Zhao LJ; Xu H; Qu JW; Zhao WZ; Zhao YB; Wang JH
Asian Pac J Cancer Prev; 2012; 13(8):3631-6. PubMed ID: 23098446
[TBL] [Abstract][Full Text] [Related]
16. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
Gu J; Fang X; Hao J; Sha X
Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
[TBL] [Abstract][Full Text] [Related]
18. [Reversing multidrug resistance in breast cancer cell line MCF-7/ADR by small interfering RNA].
Li CB; Zhang F; Shi YR; Wei XY; Yang Y; Niu RF
Ai Zheng; 2004 Dec; 23(12):1605-10. PubMed ID: 15601546
[TBL] [Abstract][Full Text] [Related]
19. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
[TBL] [Abstract][Full Text] [Related]
20. siRNA Targeting of MDR1 Reverses Multidrug Resistance in a Nude Mouse Model of Doxorubicin-resistant Human Hepatocellular Carcinoma.
Yang H; Ding R; Tong Z; Huang J; Shen L; Sun YU; Liao J; Yang Z; Hoffman RM; Wang C; Meng X
Anticancer Res; 2016 Jun; 36(6):2675-82. PubMed ID: 27272776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
